Selective decontamination of the digestive tract in critically ill children: Systematic review and meta-analysis

Pediatric Critical Care Medicine

Volumn 14, Issue 1, 2013, Pages 89-97

  Petros, Andy ^a   Silvestri, Luciano ^c   Booth, Rachelle ^b   Taylor, Nia ^d   Van Saene, Hendrick ^d  

^a Paediatric Intensive Care Unit   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c Unit of Anesthesia and Intensive Care   (Italy)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

critically ill children; infection; mortality; pediatric; pneumonia; randomized controlled trial; selective decontamination of the digestive tract

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; ANTIINFECTIVE AGENT; CEFOTAXIME; COLISTIN; NYSTATIN; PIPERACILLIN; PLACEBO; TOBRAMYCIN; VANCOMYCIN;

ASEPSIS; CHILDHOOD MORTALITY; CRITICALLY ILL PATIENT; DIGESTIVE SYSTEM; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HUMAN; INFECTION; INTENSIVE CARE; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

ANTI-BACTERIAL AGENTS; CHILD; CONFIDENCE INTERVALS; CRITICAL ILLNESS; DECONTAMINATION; GASTROINTESTINAL TRACT; HUMANS; INFECTION CONTROL; MORTALITY; ODDS RATIO; PNEUMONIA;

EID: 84873138787     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182417871     Document Type: Review

References (48)

1. de Smet AM, Kluytmans JA, Cooper BS, et al: Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360:20-31
2. Silvestri L, de la Cal MA, van Saene HKF: Selective Decontamina¬tion of the Digestive Tract (SDD). Twenty Five Years of European Experience. WFSICCM Congress Firenze 2009. Gullo A: Intensive and Critical Care Medicine. Milan, Italy, Springer Verlag, 2009, pp 273-283
3. van Saene HKF, Damjanovic V, Alcock SR: Basics in microbiology for the patient requiring intensive care. Curr Anaesth Crit Care 2001; 12:6-17
4. Johanson WG, Pierce AK, Sanford JP: Changing pharyngeal bacterial flora of hospitalized patients. Emergence of Gram-negative bacilli. N Engl J Med 1969; 281:1137-1140
5. Chang FY, Singh N, Gayowski T, et al: Staphylococcus aureus nasal colonization in patients with cirrhosis: Prospective assessment of association with infection. Infect Control Hosp Epidemiol 1998; 19:328-332
6. van Saene HKF, Damjanovic V, Murray AE, et al: How to classify infec¬tions in intensive care units. The carrier state, a criterion whose time has come? J Hosp Infect 1996; 33:1-12
7. Sands R, Manning JC, Vyas H, et al: Characteristics of deaths in paediatric intensive care: A 10-Year study. Nurs Crit Care 2009; 14:235-240
8. Gregory CJ, Nasrollahzadeh F, Dharmar M, et al: Comparison of criti¬cally ill and injured children transferred from referring hospitals versus in-house admissions. Pediatrics 2008; 121:e906-E911
9. Alexander J, Tregea S, Slater A, et al: Report of the Australian and New Zealand Paediatric Intensive Care Registry. 2010. Available at: Http://www.anzics.com.au/core/anzpicr?start=2. Accessed Septem¬ber 29, 2011
10. Heyland DK, Cook DJ, Jaeschke R, et al: Selective decontamination of the digestive tract: An overview. Chest 1994; 105:1221-1229
11. Brazzi L, Liberati A: A review of design and conduct of the available studies on selective decontamination of the digestive tract. Reanima¬tion Urgences 1992; 1:501-507
12. Silvestri L, van Saene HK, Milanese M, et al: Selective decontami¬nation of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect 2007; 65:187-203
13. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosoco¬mial infections. Am J Infect Control 1988; 16:128-140
14. Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at: Http://www.cochrane-handbook. org. Accessed September 29, 2011
15. Cucherat M, Boissel JP, Leizorovicz A. EasyMA: A program for the meta-Analysis of clinical trails. Comput Methods Programs Biomed 1997; 53:187-190
16. Leclerc F, Noizet O: Does selective digestive decontamination pre¬vent nosocomial infections? Archives de Pédiatrie 2004; 11:175-79
17. Zobel G, Kuttnig M, Grubbauer HM, et al: Reduction of colo¬nization and infection rate during pediatric intensive care by 19:1242-1246
18. Smith SD, Jackson RJ, Hannakan CJ, et al: Selective decontamination in pediatric liver transplants. A randomized prospective study. Trans¬plantation 1993; 55:1306-1309
19. Ruza F, Alvarado F, Herruzo R, et al: Prevention of nosocomial infec¬tion in a pediatric intensive care unit (PICU) through the use of selec¬tive digestive decontamination. Eur J Epidemiol 1998; 14:719-727
20. Barret JP, Jeschke MG, Herndon DN: Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 2001; 27:439-445
21. Sarginson RE, Taylor N, Reilly N, et al: Infection in prolonged pediatric critical illness: A prospective four-Year study based on knowledge of the carrier state. Crit Care Med 2004; 32:839-847
22. Elward AM, Warren DK, Fraser VJ: Ventilator-Associated pneumonia in pediatric intensive care unit patients: Risk factors and outcomes. Pediatrics 2002; 109:758-764
23. Venkatachalam V, Hendley JO, Willson DF: The diagnostic dilemma of ventilator-Associated pneumonia in critically ill children. Pediatr Crit Care Med 2011; 12:286-296
24. Petros AJ, Marshall J, van Saene HKF: Should morbidity replace mor¬tality as an endpoint for clinical trials in intensive care? Lancet 1995; 345:369-371
25. Zandstra DF, Petros AJ, Taylor N, et al: Withholding selective decon¬tamination of the digestive tract from critically ill patients must now surely be ethically questionable given the vast evidence base. Crit Care 2010; 14:443
26. 5th Consensus Conference. Prevention of hospital-Acquired sepsis in intensive care unit. Ann Franc Anesth Reanim 2009; 28: 912-920
27. García-San Vicente B, Canut A, Labora A, et al: Selective decontami¬nation of the digestive tract: Repercussions on microbiology labora¬tory workload and costs, and antibiotic resistance trends in Spanish. Enferm Infecc Microbiol Clin 2010; 28:75-81
28. de la Cal MA, van Saene HK, Silvestri L: Selective digestive tract decontamination. Enferm Infecc Microbiol Clin 2010; 28:570
29. García-San Vicente B, Canut A: Author's reply. Selective diges¬tive tract decontamination. Enferm Infecc Microbiol Clin 2010; 28:570-571
30. Oostdijk EA, de Smet AM, Blok HE, et al: Ecological effects of selec¬tive decontamination on resistant Gram-negative bacterial coloniza¬tion. Am J Respir Crit Care Med 2010; 181:452-457
31. Petros AJ, Taylor N, Damjanovic V, et al: Worlds apart: Proof that SDD works. Am J Respir Crit Care Med 2010; 182:1564
32. Ochoa-Ardila ME, García-Cañas A, Gómez-Mediavilla K, et al: Long-Term use of selective decontamination of the digestive tract does not increase antibiotic resistance: A 5-Year prospective cohort study. Intensive Care Med 2011; 37:1458-1465
33. Baxby D, van Saene HKF, Stoutenbeek CP, et al: Selective decon¬tamination of the digestive tract: 13 years on, what it is and what it is not. Intensive Care Med 1996; 22:699-706
34. Recommendations for preventing the spread of vancomycin resis¬tance. Recommendations of the Hospital Infection Control Prac¬tices Advisory Committee (HICPAC) MMWR Recomm Rep 1994; 44:1-13
35. Silvestri L, Milanese M, Oblach L, et al: Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 2002; 30:391-399
36. de la Cal MA, Cerda E, van Saene HK, et al: Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 2004; 56:175-183
37. Silvestri L, van Saene HK, Milanese M, et al: Prevention of MRSA pneumonia by oral vancomycin decontamination: A randomised trial. Eur Respir J 2004; 23:921-926
38. Viviani M, van Saene HK, Dezzoni R, et al: Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: A dose-response study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Inten¬sive Care 2005; 33:361-372
39. Thorburn K, Taylor N, Saladi SM, et al: Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococ¬cus aureus in a paediatric intensive care unit. Clin Microbiol Infect 2006; 12:35-42
40. Cerda E, Abella A, de la Cal MA, et al: Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an inten¬sive care burn unit: A 9-Year prospective study. Ann Surg 2007; 245:397-407
41. Silvestri L, Solidoro A, Milanese M, et al: Topical oropharyngeal van¬comycin to control MRSA lower airway infection in ventilated patients. Minerva Anestesiol 2010; 76:193-202
42. Currie BP, Lemos-Filho L: Evidence for biliary excretion of vancomy¬cin into stool during intravenous therapy: Potential implications for rectal colonization with vancomycin-resistant enterococci. Antimicrob Agents Chemother 2004; 48:4427-4429
43. Control of Hyperglycaemia in Paediatric intensive care. Available at: Http://www.chip-Trial.org.uk. Accessed September 29, 2011
44. Schoenfeld DA, Bernard GR: Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30:1772-1777
45. Curley MA, Zimmerman JJ: Alternative outcome measures for pediat¬ric clinical sepsis trials. Pediatr Crit Care Med 2005; 6:S150-S156
46. Bigatello LM, Hurford WE, Kacmarek RM, et al: Prolonged inhala¬tion of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994; 80:761-770
47. Roberts JD Jr, Fineman JR, Morin FC 3rd, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997; 336:605-610
48. Clark RH, Kueser TJ, Walker MW, et al: Low-Dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000; 342:469-674